Low doses of arginine butyrate derivatives improve dystrophic phenotype and restore membrane integrity in DMD models

  • S. Vianello, F. Consolaro, C. Bich, J.-M. Cancela, M. Roulot, E. Lanchec, D. Touboul, A. Brunelle, M. Israel, E. Benoit, S. de la Porte
  • The FASEB Journal, March 2014, Federation of American Societies For Experimental Biology (FASEB)
  • DOI: 10.1096/fj.13-244798

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1096/fj.13-244798